Wyeth depression/hot flash drug faces hurdles
SignOn San Diego - NEW YORK – Wyeth could win U.S. approval Monday for a depression drug derived from the company's widely used Effexor XR, but its launch will be delayed by factory problems and issues with nausea, according to Wyeth and industry analysts. The
Source: www.signonsandiego.com
Click here for more information about depression clinic depression clinic
